ProShare Advisors’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-62,631
Closed -$44.2K 2153
2025
Q1
$44.2K Sell
62,631
-17,982
-22% -$12.4K ﹤0.01% 1965
2024
Q4
$64.9K Buy
80,613
+32,262
+67% +$29.5K ﹤0.01% 2147
2024
Q3
$48K Buy
+48,351
New +$66.4K ﹤0.01% 1984
2023
Q2
Sell
-25,570
Closed -$21.8K 1892
2023
Q1
$21.8K Sell
25,570
-2,383
-9% -$2.6K ﹤0.01% 1729
2022
Q4
$36.3K Buy
27,953
+4,359
+18% +$6.79K ﹤0.01% 1767
2022
Q3
$42K Sell
23,594
-451
-2% -$1.12K ﹤0.01% 1674
2022
Q2
$54K Sell
24,045
-10,606
-31% -$25.4K ﹤0.01% 1694
2022
Q1
$114K Sell
34,651
-5,693
-14% -$20K ﹤0.01% 2007
2021
Q4
$184K Buy
40,344
+16,678
+70% +$126K ﹤0.01% 2064
2021
Q3
$170K Sell
23,666
-24,240
-51% -$178K ﹤0.01% 1826
2021
Q2
$385K Buy
+47,906
New +$404K ﹤0.01% 1724

Other funds holding OCGN

ProShare Advisors's OCGN Position: Q2 2025 in Review

ProShare Advisors sold out of Ocugen (OCGN) in Q2 2025, closing a stake of 62,631 shares — an estimated $44.2K sold.

ProShare Advisors first reported a position in OCGN in Q2 2021 and held it in 11 quarters. The position peaked at $385K in Q2 2021. 104 funds tracked by Wall St. Rank hold OCGN as of Q2 2025.

  • ProShare Advisors reported no remaining Ocugen position as of Q2 2025 after selling out during the quarter.
  • ProShare Advisors sold 62,631 Ocugen shares in Q2 2025, an estimated $44.2K.
  • ProShare Advisors first reported a position in Ocugen in Q2 2021 and held it in 11 quarters.
  • ProShare Advisors's Ocugen position peaked at $385K in Q2 2021.
  • 104 funds tracked by Wall St. Rank held Ocugen as of Q2 2025.

Based on ProShare Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.